Human medicines
Vimpat
The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed its supplied customers by fax dated September…
Prezista
The marketing authorization holder informed its supplied customers in a letter dated 07.09.2011 that due to individual reports of an unpleasant, moldy…
Cardiolite/Neurolite
The distribution company has informed its supplied customers by letter dated August 29, 2011, that the batches indicated above may be contaminated…
Calcium "Fresenius" - Ampullen
The marketing authorization holder has informed its supplied customers by letter dated 23.08.2011 that a replacement will be carried out due to…
Enapril
The marketing authorization holder informed its supplied customers in a letter dated August 12, 2011, that individual tablets may break when they are…
Saroten Retard
The marketing authorization holder informed its supplied customers in a letter dated August 9, 2011, that the release of the active ingredient may be…
Lasix
The marketing authorization holder informed its supplied customers in a letter dated July 7, 2011, that another batch that had exceeded the 18-month…
Marcoumar
In a letter dated July 13, 2011, the marketing authorization holder informed its supplied customers that, in addition to the tablets, glass splinters…
Irinoliquid
In a letter dated July 7, 2011, the marketing authorization holder informed its customers that stability tests had revealed that the active ingredient…
Xylanaest 1 % with epinephrine
The marketing authorization holder informed its supplied customers in a letter dated July 5, 2011, that due to a calculation error an incorrect…
